Dr Christian Schneider joined the National Institute for Biological Standards and Control (NIBSC) in January 2016, taking over as Director in April 2016. NIBSC is a centre of the Medicines and Healthcare products Regulatory Agency (MHRA).
Christian is qualified in medicine and previously worked as Medical Head of Division Medicines Licensing and Availability at the Danish Medicines Agency, Head of Division EU Cooperation/Microbiology at the Paul-Ehrlich Institute in Germany, and was a postdoctoral researcher at the Max-Planck-Institute for Neurobiology (Germany).
He has a strong scientific background with an extensive publication record and a wealth of experience with a broad range of biological medicinal products.
Christian is also a former Chair of the Committee for Advanced Therapies at the European Medicines Agency (EMA), and former Chair of EMA’s Biosimilar Working Party, as well as being a former co-opted member of EMA’s Committee for Medicinal Products for Human Use (CHMP) (co-opted because of his expertise in the quality and safety of biological medicinal products).
Christian also acts as Head of Profession for scientists and engineers with in the Medicines and Healthcare products Regulatory Agency as a whole.
Director of National Institute for Biological Standards and Control (NIBSC)
The National Institute for Biological Standards and Control is a world leader in product testing to assure the quality of biological medicines. They develop standards and reference materials and carrying out applied research.